Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
4,442,507
-
Share change
-
+779,709
-
Total reported value
-
$184,712,034
-
Put/Call ratio
-
0%
-
Price per share
-
$41.58
-
Number of holders
-
79
-
Value change
-
+$33,192,286
-
Number of buys
-
37
-
Number of sells
-
33
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q1 2019
As of 31 Mar 2019,
SPDR SERIES TRUST - S&P PHARMAC (XPH) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,442,507 shares.
The largest 10 holders included
CREDIT SUISSE AG/, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, DEUTSCHE BANK AG\, BARCLAYS PLC, BANK OF AMERICA CORP /DE/, Wharton Business Group, LLC, JPMORGAN CHASE & CO, WELLS FARGO & COMPANY/MN, and Hochman Cole Investment Advisors, Inc..
This page lists
79
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.